Apriso 0.375gm Capsules

Manufacturer BAUSCH HEALTH Active Ingredient Mesalamine Long-Acting Capsules (Apriso)(me SAL a meen) Pronunciation me SAL a meen
It is used to treat ulcerative colitis. It is used to help keep ulcerative colitis flares from coming back.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Anti-inflammatory agent, Aminosalicylate
đŸ§Ŧ
Pharmacologic Class
5-aminosalicylic acid (5-ASA) derivative
🤰
Pregnancy Category
Category B
✅
FDA Approved
Oct 2008
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Apriso is a medication used to help keep ulcerative colitis (a type of inflammatory bowel disease) in remission. It works by reducing inflammation in your colon. It's a long-acting capsule that you take once a day.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, follow your doctor's instructions carefully. Read all the information provided with your prescription and follow the instructions closely. You can take this medication with or without food, but be sure to swallow it whole with a full glass of water. Do not chew, open, or crush the medication. If you have difficulty swallowing, consult your doctor for guidance.

Continue taking your medication as directed by your doctor or healthcare provider, even if you start to feel better. However, do not take antacids at the same time as this medication. If you need to take an antacid, talk to your doctor about the best time to take it.

Storing and Disposing of Your Medication

Store your medication at room temperature in a dry place, away from the bathroom. Some products may come with a desiccant (a packet that protects the medication from moisture) in the container. If your container has a desiccant, keep it in the bottle. If you're unsure about storing your medication, consult your doctor or pharmacist. Keep all medications in a safe place, out of the reach of children and pets.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and return to your regular schedule. Do not take two doses at the same time or take extra doses to make up for a missed one.
💡

Lifestyle & Tips

  • Take Apriso exactly as prescribed by your doctor. Do not chew, crush, or break the capsules.
  • Swallow the capsules whole.
  • Apriso can be taken with or without food.
  • Stay well-hydrated while taking this medication.
  • Continue to follow your doctor's recommendations for diet and other lifestyle changes for managing ulcerative colitis.
  • Do not stop taking Apriso without consulting your doctor, even if you feel better, as this can lead to a relapse of your condition.
💊

Available Forms & Alternatives

Available Strengths:

Generic Alternatives:

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: 1.5 g (four 0.375 g capsules) orally once daily
Dose Range: 1.5 - 1.5 mg

Condition-Specific Dosing:

maintenance_of_remission_of_ulcerative_colitis: 1.5 g (four 0.375 g capsules) orally once daily
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: For children 10 years of age and older: 1.5 g (four 0.375 g capsules) orally once daily for maintenance of remission of ulcerative colitis.
Adolescent: 1.5 g (four 0.375 g capsules) orally once daily for maintenance of remission of ulcerative colitis.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: Use with caution; monitor renal function.
Moderate: Use with caution; monitor renal function. Avoid if possible.
Severe: Contraindicated or not recommended due to increased risk of renal toxicity.
Dialysis: Not recommended; mesalamine and its metabolites are dialyzable, but risk of toxicity outweighs benefits.

Hepatic Impairment:

Mild: Use with caution; monitor liver function.
Moderate: Use with caution; monitor liver function.
Severe: Use with caution; monitor liver function. Avoid if possible.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Mesalamine is an aminosalicylate that exerts its therapeutic effect locally in the colonic mucosa. Its exact mechanism is not fully understood but is thought to involve modulation of inflammatory mediators (e.g., leukotrienes, prostaglandins), inhibition of cytokine production, and scavenging of free radicals. It reduces inflammation in the colon, which is characteristic of ulcerative colitis.
📊

Pharmacokinetics

Absorption:

Bioavailability: Approximately 25% (systemic absorption for Apriso, designed for local action)
Tmax: 4-12 hours (for mesalamine)
FoodEffect: High-fat meal may delay Tmax and slightly increase systemic exposure, but overall absorption is not significantly affected to warrant specific food instructions.

Distribution:

Vd: Not readily available for specific formulation, but generally low systemic distribution due to local action.
ProteinBinding: Approximately 43% for mesalamine; 78% for N-acetylmesalamine.
CnssPenetration: Limited

Elimination:

HalfLife: 8-12 hours (mesalamine); 10-15 hours (N-acetylmesalamine)
Clearance: Not readily available for specific formulation, primarily renal and fecal.
ExcretionRoute: Renal (primarily as N-acetylmesalamine) and fecal (unabsorbed mesalamine).
Unchanged: Less than 1% (systemically absorbed mesalamine)
âąī¸

Pharmacodynamics

OnsetOfAction: Not acutely acting; effects for maintenance of remission are observed over weeks.
PeakEffect: Not applicable for acute effect; sustained local anti-inflammatory action.
DurationOfAction: 24 hours (due to extended-release formulation allowing once-daily dosing).

Safety & Warnings

âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness or swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to urinate or changes in urine output
+ Blood in the urine or significant weight gain
+ Back pain, abdominal pain, or blood in the urine (which may indicate a kidney stone)
Chest pain or pressure, rapid or irregular heartbeat
Fever, chills, sore throat, unexplained bruising or bleeding, or feeling extremely tired or weak
Symptoms that may resemble ulcerative colitis, such as:
+ New or worsening stomach pain or cramps
+ Bloody stools
+ Fever
+ Headache
+ Itching or rash
+ Red or pink eyes
+ Feeling unwell
Signs of liver problems, which can be rare but potentially life-threatening:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of heart problems, which can be rare but potentially life-threatening:
+ Shortness of breath
+ Significant weight gain
+ Swelling in the arms or legs
Severe skin reactions, including:
+ Stevens-Johnson syndrome (SJS)
+ Toxic epidermal necrolysis (TEN)
+ Other serious reactions that can affect body organs and be life-threatening
+ Symptoms may include:
- Red, swollen, blistered, or peeling skin
- Red or irritated eyes
- Sores in the mouth, throat, nose, eyes, genitals, or skin
- Fever
- Chills
- Body aches
- Shortness of breath
- Swollen glands

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, contact your doctor for advice:

Constipation
Diarrhea
Stomach pain or upset stomach
Vomiting
Heartburn
Gas
Burping
Nose or throat irritation
Dizziness or headache
Back pain
* Cough

This list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • New or worsening abdominal pain, cramping, or bloody diarrhea (could indicate acute intolerance syndrome or worsening UC)
  • Signs of kidney problems: swelling in your ankles or feet, changes in how much you urinate, unusual tiredness
  • Signs of liver problems: yellowing of your skin or eyes (jaundice), dark urine, persistent nausea or vomiting, severe stomach pain
  • Signs of blood problems: unusual bleeding or bruising, fever, sore throat, extreme tiredness
  • Signs of allergic reaction: rash, hives, itching, swelling of your face/lips/tongue/throat, difficulty breathing, chest pain
  • Signs of heart inflammation (pericarditis/myocarditis): chest pain, shortness of breath, palpitations
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the symptoms you experienced during an allergic reaction.
Existing health conditions, including:
+ Kidney disease or liver disease
+ Stomach or bowel ulcers
+ Narrowing of the stomach valve or other types of stomach blockages
+ Blockages in the urinary tract (consult with your healthcare provider)
Other medications you are taking, including:
+ Prescription and over-the-counter (OTC) drugs
+ Natural products
+ Vitamins
Other health problems you are experiencing

This list is not exhaustive, and it is crucial to discuss all your medications and health issues with your doctor and pharmacist to ensure safe use. Never start, stop, or change the dosage of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests will be necessary, as directed by your doctor, to monitor your condition. Be sure to discuss any concerns or questions with your doctor.

This medication may interfere with certain laboratory tests, so it is crucial to notify all your healthcare providers and laboratory personnel that you are taking this drug.

To stay hydrated, drink plenty of non-caffeinated fluids, unless your doctor advises you to limit your liquid intake.

If you have phenylketonuria (PKU), consult with your doctor before taking this medication, as some products may contain phenylalanine.

While taking this medication, you may notice that your urine turns reddish-brown when it comes into contact with surfaces or water that have been treated with bleach, such as in the toilet. However, if you notice that your urine is reddish-brown before it comes into contact with any surfaces or water that may have been treated with bleach, contact your doctor.

You may be more susceptible to sunburn while taking this medication. To minimize this risk, avoid exposure to the sun, sunlamps, and tanning beds, and use sunscreen and protective clothing and eyewear when going outside.

If you are 65 years or older, use this medication with caution, as you may be more prone to side effects.

Not all formulations of this medication are suitable for children. Before giving this medication to a child, consult with your doctor to determine the appropriate dosage and potential risks.

Do not give this medication to children and teenagers who have or are recovering from flu symptoms, chickenpox, or other viral infections, as this may increase the risk of Reye's syndrome, a rare but serious condition that can cause severe brain and liver damage.

If you are pregnant, plan to become pregnant, or are breastfeeding, inform your doctor, as they will need to discuss the potential benefits and risks of this medication with you and determine the best course of treatment for you and your baby.
🆘

Overdose Information

Overdose Symptoms:

  • Nausea
  • Vomiting
  • Abdominal pain
  • Diarrhea
  • Headache
  • Drowsiness
  • Vertigo
  • Tinnitus
  • Confusion
  • Hyperventilation (rare, but possible with very high doses)

What to Do:

Seek immediate medical attention or call a poison control center (1-800-222-1222). Treatment is supportive and symptomatic. There is no specific antidote.

Drug Interactions

🔴

Major Interactions

  • Azathioprine
  • Mercaptopurine
🟡

Moderate Interactions

  • NSAIDs (e.g., ibuprofen, naproxen)
  • Nephrotoxic agents (e.g., tacrolimus, cyclosporine)
  • Lactulose

Monitoring

đŸ”Ŧ

Baseline Monitoring

Renal function (BUN, serum creatinine)

Rationale: To assess baseline kidney function and identify pre-existing impairment, as mesalamine can cause renal toxicity.

Timing: Prior to initiation of therapy.

Liver function tests (ALT, AST, bilirubin)

Rationale: To assess baseline liver function, as mesalamine can rarely cause hepatotoxicity.

Timing: Prior to initiation of therapy.

Complete Blood Count (CBC) with differential

Rationale: To assess baseline hematologic status, as mesalamine can rarely cause blood dyscrasias.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Renal function (BUN, serum creatinine)

Frequency: Periodically (e.g., every 3-6 months or as clinically indicated), especially during the first year of treatment and with concomitant nephrotoxic drugs.

Target: Within normal limits for age and sex.

Action Threshold: Significant increase in creatinine or BUN; consider dose adjustment or discontinuation.

Liver function tests (ALT, AST, bilirubin)

Frequency: Periodically (e.g., annually or as clinically indicated).

Target: Within normal limits.

Action Threshold: Significant elevation; investigate and consider discontinuation.

Complete Blood Count (CBC) with differential

Frequency: Periodically (e.g., annually or as clinically indicated), especially if patient develops unexplained bleeding, bruising, purpura, sore throat, fever, or malaise.

Target: Within normal limits.

Action Threshold: Significant decrease in cell counts (e.g., leukopenia, neutropenia, thrombocytopenia); investigate and consider discontinuation.

đŸ‘ī¸

Symptom Monitoring

  • Worsening of ulcerative colitis symptoms (e.g., increased abdominal pain, diarrhea, rectal bleeding)
  • Signs of renal impairment (e.g., decreased urine output, swelling in ankles/feet)
  • Signs of liver injury (e.g., yellowing of skin/eyes, dark urine, persistent nausea/vomiting, severe abdominal pain)
  • Signs of blood dyscrasias (e.g., unexplained bleeding, bruising, purpura, sore throat, fever, malaise)
  • Signs of hypersensitivity reactions (e.g., rash, fever, difficulty breathing, chest pain, pericarditis, myocarditis, lupus-like syndrome)
  • Signs of acute intolerance syndrome (e.g., cramping, acute abdominal pain, bloody diarrhea, fever, headache, rash)

Special Patient Groups

🤰

Pregnancy

Mesalamine crosses the placenta. While generally considered low risk, use during pregnancy only if the potential benefit justifies the potential risk to the fetus. Uncontrolled inflammatory bowel disease poses greater risks to pregnancy outcomes than mesalamine exposure.

Trimester-Specific Risks:

First Trimester: Limited data, but no clear evidence of increased risk of major birth defects.
Second Trimester: Generally considered safe, continued use often recommended if needed to maintain remission.
Third Trimester: No specific risks identified, but monitor for signs of renal dysfunction in the neonate if exposed late in pregnancy.
🤱

Lactation

Mesalamine and its metabolite are excreted in breast milk in small amounts. Monitor breastfed infants for signs of diarrhea. Generally considered compatible with breastfeeding, but caution is advised.

Infant Risk: Low; potential for mild diarrhea in the infant. Discontinue breastfeeding if significant diarrhea occurs.
đŸ‘ļ

Pediatric Use

Apriso is approved for maintenance of remission of ulcerative colitis in pediatric patients 10 years of age and older. Safety and effectiveness in pediatric patients younger than 10 years have not been established.

👴

Geriatric Use

Use with caution in elderly patients, as they are more likely to have decreased renal function. Monitor renal function closely. No specific dose adjustment is typically required based on age alone, but individual assessment is crucial.

Clinical Information

💎

Clinical Pearls

  • Apriso is an extended-release formulation of mesalamine designed for once-daily dosing, which can improve patient adherence.
  • It is indicated for the maintenance of remission of ulcerative colitis, not for the treatment of acute flares.
  • Patients should be instructed to swallow the capsules whole and not to chew, crush, or break them, as this would alter the extended-release properties.
  • Mesalamine can rarely cause an acute intolerance syndrome, which may mimic a flare of ulcerative colitis (cramping, acute abdominal pain, bloody diarrhea, fever, headache, rash). If this occurs, discontinue the drug and evaluate the patient.
  • Regular monitoring of renal function is important due to the potential for mesalamine-induced nephrotoxicity, especially in patients with pre-existing renal impairment or those taking other nephrotoxic drugs.
🔄

Alternative Therapies

  • Other oral mesalamine formulations (e.g., Lialda, Asacol HD, Pentasa, sulfasalazine)
  • Rectal mesalamine formulations (e.g., Canasa suppositories, Rowasa enema) for distal colitis
  • Corticosteroids (e.g., prednisone, budesonide) for induction of remission
  • Immunomodulators (e.g., azathioprine, mercaptopurine, methotrexate)
  • Biologic agents (e.g., infliximab, adalimumab, vedolizumab, ustekinumab)
  • JAK inhibitors (e.g., tofacitinib, upadacitinib)
💰

Cost & Coverage

Average Cost: Varies widely, typically $500-$1000+ per 30 capsules
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (Brand name), Tier 1 (Generic mesalamine)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so it's a good idea to check with your pharmacist. If you have any questions or concerns about this medication, don't hesitate to discuss them with your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide detailed information about the overdose, including the medication taken, the amount, and the time it occurred.